Primary sclerosing cholangitis and the gut microbiota - a study on mice, man and microbes
Metadata
Show metadataAppears in the following Collection
- Institutt for klinisk medisin [10814]
Abstract
No abstract.List of papers
Paper I Kummen M, Holm K, Anmarkrud JA, Nygård S, Vesterhus M, Høivik ML, Trøseid M, Marschall HU, Schrumpf E, Moum B, Røsjø H, Aukrust P, Karlsen TH, Hov JR. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from ulcerative colitis patients without biliary disease and healthy controls. Published as: The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. Gut. 2016 Feb 17. An author version is available in DUO: http://urn.nb.no/URN:NBN:no-56234 |
Paper II Kummen M, Vesterhus M, Trøseid M, Moum B, Svardal A, Boberg KM, Aukrust P, Karlsen TH, Berge RK, Hov JR. Microbiota-dependent marker trimethylamine-N-oxide (TMAO) is associated with the severity of primary sclerosing cholangitis. Published as: Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function. United European Gastroenterol J. 2016 Aug 2. An author version is available in DUO: http://urn.nb.no/URN:NBN:no-56235 |
Paper III Schrumpf E, Kummen M, Greiner T, Holm K, Arulampalam V, Baines J, Bäckhed F, Karlsen TH, Blumberg RS, Hov JR, Melum E. The gut microbiota contributes to disease in a mouse model with spontaneous bile duct inflammation. J Hepatol. 2016. Oct 5. An author version is available in DUO: http://urn.nb.no/URN:NBN:no-56236 |